KBLMR180 Life Sciences Corp.

Nasdaq 180lifesciences.com


$ 0.40 $ 0.01 (3.19 %)    

Friday, 06-Nov-2020 15:56:07 EST
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 0.392
$ 0.18 x 500
$ 0.40 x 800
-- - --
$ 0.03 - $ 0.41
1,316,736
na
1.72M
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-23-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-15-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 07-16-2021 03-31-2021 10-Q
13 07-09-2021 12-31-2020 10-K
14 11-24-2020 09-30-2020 10-Q
15 08-20-2020 06-30-2020 10-Q
16 05-22-2020 03-31-2020 10-Q
17 04-07-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-29-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Me...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION